PUBLIC POLICY STATEMENT ON DRUG TESTING AS A COMPONENT OF ADDICTION TREATMENT AND MONITORING PROGRAMS AND IN OTHER CLINICAL SETTINGS
Sábháilte in:
AMERICAN SOCIETY OF ADDICTION MEDICINE, PUBLIC POLICY STATEMENT ON DRUG TESTING AS A COMPONENT OF ADDICTION TREATMENT AND MONITORING PROGRAMS AND IN OTHER CLINICAL SETTINGS. JOURNAL OF ADDICTIVE DISEASES, Vol. 22, no. 3 (2003), p. 114-119.
Ref.
126428
Suíomh:
SIIS R.926 Archivo
Palabras clave:
Análisis clínicos, Declaración, Detección, Drogodependencias, Recomendaciones
Análisis clínicos, Declaración, Detección, Drogodependencias, Recomendaciones
Míreanna comhchosúla: PUBLIC POLICY STATEMENT ON DRUG TESTING AS A COMPONENT OF ADDICTION TREATMENT AND MONITORING PROGRAMS AND IN OTHER CLINICAL SETTINGS
- PUBLIC POLICY STATEMENT ON DRUG TESTING IN WORKPLACE SETTINGS
- PUBLIC POLICY STATEMENT ON SCREENING FOR ADDICTION IN PRIMARY CARE SETTINGS
- QUANTITATIVE URINE DRUG MONITORING IN METHADONE PROGRAMS: POTENTIAL CLINICAL USES
- USE OF LABORATORY TESTS TO MONITOR HEAVY DRINKING BY ALCOHOLIC MEN DISCHARGED FROM A TREATMENT PROGRAM
- PUBLIC POLICY STATEMENT ON MARIJUANA
- DRUG USE MONITORING IN AUSTRALIA (DUMA). DRUG DETECTION TESTING